COMMUNIQUÉS West-GlobeNewswire

The American Society of Pain and Neuroscience (ASPN) Issues Consensus Guidelines on Peripheral Nerve Stimulation
19/11/2025
- Guidelines support increasing treatment access for patients given the clinical evidence in addressing chronic pain - CLEVELAND, Nov. 19, 2025 (GLOBE NEWSWIRE) -- The American Society of Pain and Neuroscience (ASPN) [...]
Salarius Pharmaceuticals Cites Errors on S&P CapIQ Platform Following Merger with Decoy Therapeutics, Affirms Its Shares Continue to Trade on the Nasdaq Stock Market Under the Symbol “SLRX”
19/11/2025
Company has pro forma cash of approximately $14 million following recent public offering HOUSTON and CAMBRIDGE, Mass., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (Salarius or the [...]
Patriot Mobile Named SoldierStrong’s 2025 Corporate Recipient of the Annual Commitment to Service Award
19/11/2025
STAMFORD, Conn., Nov. 19, 2025 (GLOBE NEWSWIRE) -- SoldierStrong, the national nonprofit committed to delivering revolutionary medical technologies to America’s veterans, is proud to announce Patriot Mobile as the 2025 [...]
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
19/11/2025
PALO ALTO, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that on [...]
Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference
19/11/2025
CARLSBAD, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, Chairman and CEO of Carlsmed, will be presenting at the 37th Annual [...]
ImPact Biotech to Present Updated Interim Phase 3 Data from ENLIGHTED Study of Padeliporfin VTP in Low Grade UTUC at SUO 2025
19/11/2025
TEL AVIV, Israel, Nov. 19, 2025 (GLOBE NEWSWIRE) -- ImPact Biotech, a clinical-stage biotechnology company focused on developing Padeliporfin vascular targeted photodynamic (VTP) therapy to treat a range of solid tumors [...]
Meihua International Announces 1-For-100 Reverse Share Split
19/11/2025
YANGZHOU, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Meihua International Medical Technologies Co., Ltd. (“Meihua” or the “Company”) (Nasdaq: MHUA), reputable manufacturer and provider of Class I, II, and III disposable medical [...]
OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference
19/11/2025
MIAMI, Nov. 19, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Piper Sandler 37 th Annual Healthcare Conference, being held December 2-4, 2025 at [...]
SynCardia Completes First In Vivo Implantations of Next-Generation Emperor Total Artificial Heart
19/11/2025
Significant milestone reached in advancing a driverless total artificial heart, strengthening Picard Medicals leadership in total artificial heart technology TUCSON, Ariz., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Picard [...]
Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference
19/11/2025
SUNNYVALE, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological [...]
EYLEA HD® (aflibercept) Injection 8 mg Approved by FDA for the Treatment of Macular Edema Following Retinal Vein Occlusion (RVO) and for Monthly Dosing Across Approved Indications
19/11/2025
First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing option in all approved indications provides greater dosing flexibility for more [...]
ZyVersa Therapeutics Reports Third Quarter 2025 Financial Results
19/11/2025
ZyVersa is advancing a therapeutic development pipeline with multiple programs built around its two proprietary technologies – Cholesterol Efflux Mediator VAR 200 for treatment of kidney diseases, and Inflammasome ASC [...]
Vivos Therapeutics Reports Significant Revenue Growth During the Third Quarter 2025
19/11/2025
Financial results highlighted by 78% sequential quarter over quarter revenue growth, showing the impact of the first full quarter of Sleep Center of Nevada operations Management to host conference call today at 5:00 pm [...]
Arch Biopartners Closes Non-Brokered Private Placement
19/11/2025
TORONTO, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Arch Biopartners Inc ., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today it has closed a non-brokered private placement offering of 576,923 [...]
Heartflow to Participate in the Piper Sandler 37th Annual Healthcare Conference
19/11/2025
MOUNTAIN VIEW, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in artificial intelligence (AI) technology for coronary artery disease (CAD), today announced that members [...]
InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference
19/11/2025
MIAMI, Nov. 19, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard ® Prime carotid stent system for the prevention of stroke, today announced plans to participate in a fireside discussion [...]
FDA Pilots Faster Clarifications to Meeting Minutes
19/11/2025
Silver Spring, Md., Nov. 19, 2025 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced a pilot program designed to streamline communications with sponsors following formal meetings. Through the [...]
LUKE and Asset Health Forge National Partnership to Advance Human Flourishing for America’s Heroes
19/11/2025
ROCKLEDGE, Fla., Nov. 19, 2025 (GLOBE NEWSWIRE) -- LUKE Holdings, Inc. (“LUKE”), a trusted leader in healthcare staffing for the United States Government, today announced a strategic partnership with Asset Health, a [...]
Fennec Pharmaceuticals Announces Completion Of Full Debt Redemption
19/11/2025
RESEARCH TRIANGLE PARK, N.C., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a specialty pharmaceutical company, today announced it has repurchased and [...]

Pages